|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phenyl glycidyl ether |
CAS 122-60-1 | ||
C9H10O2 |
RTECS TZ3675000 | ||
|
Synonyms & Trade Names 1,2-Epoxy-3-phenoxy propane; Glycidyl phenyl ether; PGE; Phenyl 2,3-epoxypropyl ether |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: Ca C 1 ppm (6 mg/m3) [15-minute] See Appendix A | ||
| OSHA PEL†: TWA 10 ppm (60 mg/m3) | |||
| IDLH Ca [100 ppm] See: 122601 | Conversion 1 ppm = 6.14 mg/m3 | ||
|
Physical Description Colorless liquid. [Note: A solid below 38°F.] |
|||
|
MW: 150.1 |
BP: 473°F |
FRZ: 38°F |
Sol: 0.2% |
|
VP: 0.01 mmHg |
IP: ? |
|
Sp.Gr: 1.11 |
|
Fl.P: 248°F |
UEL: ? |
LEL: ? |
|
| Class IIIB Combustible Liquid: Fl.P. at or above 200°F. | |||
|
Incompatibilities & Reactivities Strong oxidizers, amines, strong acids, strong bases |
|||
|
Measurement Methods NIOSH 1619; OSHA 7 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; upper respiratory system; skin sensitization; narcosis; possible hematopoietic, reproductive effects; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, central nervous system, hematopoietic system, reproductive system Cancer Site [in animals: nasal cancer] |
|
| See also: INTRODUCTION See ICSC CARD: 0188 See MEDICAL TESTS: 0183 |